Sprague-Dawley 수컷에 streptozotocin (50 mg/kg body weight)을 복강 주사하여 유발시킨 당뇨군에서 베타인(1%, w/w) 첨가에 의한 항당뇨 및 간보호 효과를 검토하였다. Streptozotocin-유발 당뇨군에서 혈당치 및 fructosamine 농도가 현저히 증가하였고, 이러한 증가는 베타인 투여로 감소하였다. 간 기능의 biomarker로 사용되는 alanine aminotransferase (AST) 및 aspartate aminotransferase (ALT) 활성은 당뇨군에서 현저히 증가한 반면 간보호 효과가 있는 베타인 투여 당뇨군에서는 정상군 수준으로 회복됨으로써 당뇨성 간 손상에 효과가 있는 것으로 나타났다. 혈중 중성지질 농도는 당뇨군에서 현저히 증가하였으나, 베타인 투여에 의해 정상군 수준까지 감소하였으나, 총 콜레스테롤 농도는 베타인 첨가에 의해 증가하였다. 췌장 조직의 조직검사에서 췌도 세포의 정상적인 타원형 모양이 정상군에서는 잘 유지되었으나, Streptozotocin-유발 당뇨군에서는 췌도 세포의 파괴가 일어났으며, 베타인 투여에 의해서는 회복된 것으로 나타났다. 이상의 결과로 볼 때 당뇨군에서 베타인 투여에 의한 혈당강하 효과는 췌장의 췌도세포 파괴 억제에 의한 것으로 시사되었다.
Sprague-Dawley 수컷에 streptozotocin (50 mg/kg body weight)을 복강 주사하여 유발시킨 당뇨군에서 베타인(1%, w/w) 첨가에 의한 항당뇨 및 간보호 효과를 검토하였다. Streptozotocin-유발 당뇨군에서 혈당치 및 fructosamine 농도가 현저히 증가하였고, 이러한 증가는 베타인 투여로 감소하였다. 간 기능의 biomarker로 사용되는 alanine aminotransferase (AST) 및 aspartate aminotransferase (ALT) 활성은 당뇨군에서 현저히 증가한 반면 간보호 효과가 있는 베타인 투여 당뇨군에서는 정상군 수준으로 회복됨으로써 당뇨성 간 손상에 효과가 있는 것으로 나타났다. 혈중 중성지질 농도는 당뇨군에서 현저히 증가하였으나, 베타인 투여에 의해 정상군 수준까지 감소하였으나, 총 콜레스테롤 농도는 베타인 첨가에 의해 증가하였다. 췌장 조직의 조직검사에서 췌도 세포의 정상적인 타원형 모양이 정상군에서는 잘 유지되었으나, Streptozotocin-유발 당뇨군에서는 췌도 세포의 파괴가 일어났으며, 베타인 투여에 의해서는 회복된 것으로 나타났다. 이상의 결과로 볼 때 당뇨군에서 베타인 투여에 의한 혈당강하 효과는 췌장의 췌도세포 파괴 억제에 의한 것으로 시사되었다.
This study was to investigate the effect of betaine on the hypoglycemia and hepatoprotection of streptozotocin(STZ)-induced diabetic rats. Male Sprague-Dawley rats weighing around 280 g were randomly assigned to the three experimental groups: a healthy normal group and two groups with STZ-induced di...
This study was to investigate the effect of betaine on the hypoglycemia and hepatoprotection of streptozotocin(STZ)-induced diabetic rats. Male Sprague-Dawley rats weighing around 280 g were randomly assigned to the three experimental groups: a healthy normal group and two groups with STZ-induced diabetes and fed either control diet or betaine diet. Betaine given to the STZ-diabetic rats had significant effect in lowering the serum glucose concentrations compared to the STZ-diabetic rats. The alanine aminotransferase (AST) and aspartate aminotransferase (ALT) activities and triglyceride contents in serum were dramatically higher in the STZ-diabetic rats, but these increases in relation to diabetes also decreased in the STZ-diabetic rats fed betaine. However, the total-cholesterol concentration in the STZ-diabetic rats was even increased by betaine. The morphology of the pancreatic islets in the normal rats showed a typical round form, but most of the islets in the STZ-diabetic rats showed severe morphological alterations by being markedly destroyed. However, the islet morphology of STZ-diabetic rats given betaine mostly maintained a normal rounded appearance. The present study strongly suggests that the administration of betaine showed a moderate hypoglycemic effect by protecting the pancreatic beta-cells by morphological examination from STZ-induced destruction.
This study was to investigate the effect of betaine on the hypoglycemia and hepatoprotection of streptozotocin(STZ)-induced diabetic rats. Male Sprague-Dawley rats weighing around 280 g were randomly assigned to the three experimental groups: a healthy normal group and two groups with STZ-induced diabetes and fed either control diet or betaine diet. Betaine given to the STZ-diabetic rats had significant effect in lowering the serum glucose concentrations compared to the STZ-diabetic rats. The alanine aminotransferase (AST) and aspartate aminotransferase (ALT) activities and triglyceride contents in serum were dramatically higher in the STZ-diabetic rats, but these increases in relation to diabetes also decreased in the STZ-diabetic rats fed betaine. However, the total-cholesterol concentration in the STZ-diabetic rats was even increased by betaine. The morphology of the pancreatic islets in the normal rats showed a typical round form, but most of the islets in the STZ-diabetic rats showed severe morphological alterations by being markedly destroyed. However, the islet morphology of STZ-diabetic rats given betaine mostly maintained a normal rounded appearance. The present study strongly suggests that the administration of betaine showed a moderate hypoglycemic effect by protecting the pancreatic beta-cells by morphological examination from STZ-induced destruction.
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
대상 데이터
Seven-week-old male Sprague-Dawley rats were pur chased from Hyochang Science (Daegu, Korea), and housed individually in suspended wire-mesh stainless cages in a temperature (21-24℃) and light (08:00-20:00) controlled animal room. The composition of a semi-synthetic diet was as follows (g/kg); starch 400, casein 200, sucrose 200, com oil 100z cellulose 50, mineral mixture (AIN 93) 35, vitamin mixture (AIN 93) 10, DL-methionine 3 and choline bitartrate 2.
데이터처리
The data from animal experiments are presented as the mean+S.E., and were analyzed using a one way analysis of variance (ANOVA), with the differences analyzed using the Duncan's new multiple-range test[7]. A p value <0.
참고문헌 (30)
Anonymous. 1996. Proscription Drug Product List. 16th ed. Washington, DC: US Food and Drug Administration
Bessieres, M. A., Y. Gibon, J. C. Lefeuvre and F. A. Larher. 1999. Single-step purification for glycine betaine determination in plant extracts by isocratic HPLC. J. Agric. Food Chem. 47, 3718-3722
Bostom, A. G., D. Shemin, M. R. Nadeau, V. Shih and S. P. Stabler. 1995. Short term betaine therapy fails to lower elevated fasting total plasma homocysteine concentrations in hemodialysis patients maintained on chronic folic acid supplementation. Atheosclerosis 113, 129-132
Cha, J. Y., B. S. Jeon, J. W. Park, G. G. Shin, B. K. Kim, H. K. Kim and Y. S. Cho. 2004. Hypoglycemic effect of mushroom fermented milk in streptozotocin induced diabetic rats. J. Life Sci. 14, 676-682
Cha, J. Y., B. S. Jeon, J. W. Park, B. K. Kim, C. Y. Jeong, J. S. Ryu, C. K. Choi and Y. S. Cho. 2004. Hypocholesterolemic effect of yogurt supplemented Saliconia herbacea extract in cholesterol-fed rats. J. Life Sci. 14, 747-751
DeFronzo, R. A. and E. Ferrannini. 1991. Insulin resistance : A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14, 173-194
Hoogeveen E. K., P. J. Kostense, P. J. Beks, A. J. Mackaay, C. Jakobs, L. M. Bouter, R. I. Heine and C. D. Stehouwer. 1998. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a populationbased study. Arterioscler Thromb Vasc. Biol. 18, 133-138
Janssens, G. P. J., De H. D. Rycke, M. Hesta and De R. O. M. Wilde. 1999. Analysis of carnitine, betaine, ${\gamma}-butyrobetaine$ , and separate short-chain acylcarnitines in pigeon plasma, crop milk and tissues by HPLC coupled with UV-detection. Biotechnol. Techniq. 12, 231-234
Jeon, B. S., J. W. Park, G. G. Shin, B. K. Kim, H. K. Kim, Y. S. Cho and J. Y. Cha. 2004. Effect of fermented mushroom milk on hyperlipidemia and hepatic injury in streptozotocin- induced diabetic and Zucker diabetic fatty rats. Food Sci. Biotechnol. 13, 576-580
Jia, D. M., A. Tabaru, T. Akiyama, S. Ade and M. Otsuki. 2000. Fatty liver, chronic viral hepatities and autoimmune hepatities. Troglitazone prevents fatty changes of the liver in obese diabetic rats. J. Gastroentrol. Hepatol. 15, 1183-1191
Junnila, M., A. J. Barak, H. C. Beckenhauer and T. Rahko. 1998. Betaine reduces hepatic lipidosis induced by carbon tetrachloride in Sprague-Dawley rats. Vet. Hum. Toxicol. 40, 263-266
Kiho, T., A. Sobue and S. Ukai. 1994. Structural features and hypoglycemic activities of two polysaccharides from hot-water extract of Agrocybe cylindracea. Carbohydrate Res. 251, 81-87
Konno, S., D. G. Tortorelis, S. A. Fullerton, A. A. Samadi, J. Hettiarachchi and H. Tazaki. 2001. A possible hypoglycaemic effect of Maitake mushroom on type 2 diabetic patients. Diabetic Medicine 18, 1010-1011
Lee, J. J., H. Y. Yi, J. W. Yang, J. S. Shin, J. H. Kwon and C. W. Kim. 2003. Characterization of streptozotocin-induced diabetic rats and pharmacodynamics of insulin formulations. Biosci. Biotechnol. Biochem. 67, 2396-2400
Lee, C. H., I. H. Kim, Y. E. Kim, S. W. Oh and H. J. Lee. 2004. Determination of betaine from Saliconia herbacea L. J. Korean Soc. Food Sci. Nutr. 33, 1584-1587
Ohaeri, O. C. 2001. Effect of garlic oil on the levels of various enzymes in the serum and tissue of streptozotocin diabetic rats. Bioscience Reports 21, 19-24
Olthof, M. R., T. van Vliet, P. Verhoef, P. L. Zock and M. B. Katan. 2005. Effect of homocysteine-lowering nutrients on blood lipids: results from four randomised, placebo- controlled studies in healthy humans. PLOS Med. 2(5):e135
Park, I. S., Y. Z. Che, M. Bendayan, S. W. Kang and B. H. Min. 1999. Up-regulation of clusterin (sulfated glycoprotein- 2) in pancreatic islet cells upon streptozotocin injection to rats. J. Endocrinol. 162, 57-65
Schnedl, W. J., S. J. Wallner, C. Piswanger, R. Krause and R. W. Lipp. 2005. Glycated hemoglobin and liver disease in diabetes mellitus. Wien Med. Wochenschr 155, 411-415
Talpur, N., B. W. Echard, T. Yasmin, D. Bagchi and H. G. Preuss. 2003. Effects of niacin-bound chromium, Maitake mushroom fraction SX and (-)-hydroxycitric acid on the metabolic syndrome in aged diabetic Zucker fatty rats. Mol. Cell Chem. 252, 369-377
Willett, W., J. Manson and S. Liu. 2002. Glycemic index, glycemic load, and risk of type 2 diabetes. Am. J. Clin. Nutr. 76, 274-280S
Zeisel, S. H., M. H. Mar, J. C. Howe and J. M. Holden. 2003. Concentrations of choline-containing compounds and betaine in common foods. J. Nutr. 133, 1302-1307
Zied, A., M. Ouoi, M. Chahib, E. Olfa, N. Brahim, M. Hedi, H. Habib, Z. Borni and M. Salem. 2005. Homocysteinaemia and degenerative complications in non insulin dependent diabetes mellitus. Tunis. Med. 83, 537-540
※ AI-Helper는 부적절한 답변을 할 수 있습니다.